A carregar...
Use of everolimus in liver transplantation
In recent years, the use of mammalian target of rapamycin inhibitors has gained traction in their use as alternative or adjunct immunosuppressants in the post-liver transplantation (LT) setting. The efficacy of everolimus (EVR) in de novo LT is established and a reasonable time to initiate EVR is 30...
Na minha lista:
| Publicado no: | World J Hepatol |
|---|---|
| Main Authors: | , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
Baishideng Publishing Group Inc
2017
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5569278/ https://ncbi.nlm.nih.gov/pubmed/28878864 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.4254/wjh.v9.i23.990 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|